RT Journal Article
SR Electronic
T1 Temporal and geographical variation of COVID-19 in-hospital fatality rate in Brazil
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.19.21251949
DO 10.1101/2021.02.19.21251949
A1 Tatiana Pineda Portella
A1 Sara Ribeiro Mortara
A1 Rafael Lopes
A1 Andrea Sánchez-Tapia
A1 Maria Rita Donalísio
A1 Marcia C. Castro
A1 Vito Ribeiro Venturieri
A1 Camila Genaro Estevam
A1 Ana Freitas Ribeiro
A1 Renato Mendes Coutinho
A1 Maria Amélia de Sousa Mascena Veras
A1 Paulo Inácio Prado
A1 Roberto André Kraenkel
YR 2021
UL http://medrxiv.org/content/early/2021/02/23/2021.02.19.21251949.abstract
AB Background Previous studies have shown that COVID-19 In-Hospital Fatality Rate (IHFR) varies between regions and has been diminishing over time. It is believed that the continuous improvement in the treatment of patients, age group of hospitalized, and the availability of hospital resources might be affecting the temporal and regional variation of IHFR. In this study, we explored how the IHFR varied over time and among age groups and federative states in Brazil. In addition, we also assessed the relationship between hospital structure availability and peaks of IHFR.Methods A retrospective analysis of all COVID-19 hospitalizations with confirmed outcomes in 22 states between March 01 and September 22, 2020 (n=345,281) was done. We fit GLM binomial models with additive and interaction effects between age groups, epidemiological weeks, and states. We also evaluated the association between the modeled peak of IHFR in each state and the variables of hospital structure using the Spearman rank correlation test.Results We found that the temporal variation of the IHFR was heterogeneous among the states, and in general it followed the temporal trends in hospitalizations. In addition, the peak of IHFR was higher in states with a smaller number of doctors and intensivists, and in states in which a higher percentage of people relied on the Public Health System (SUS) for medical care.Conclusions Our results suggest that the pressure over the healthcare system is affecting the temporal trends of IHFR in Brazil.Key MessagesTemporal variation of age adjusted In-Hospital Fatality Rate (IHFR) was markedly heterogeneous among Brazilian states from March to September of 2020.In several states, the IHFR increased in association with the increase in the number of hospitalizations, which suggests that the overload of the healthcare system might be affecting the temporal trends of IHFR in Brazil.The IHFR remained low in the states with higher rates of hospital resources, even with the high demand for hospitalization.The number of doctors and intensivist physicians per habitant was more strongly correlated with the peak of IHFR in the Brazilian states than the number of ICU beds.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil (Finance Code 001 to TPP, AST, CGE), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (grant number: 141698/2018-7 to RL, 313055/2020-3 to PIP, 312559/2020-8 to MASMV, 311832/2017-2 to RAK) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (contract number: 2016/01343-7 to RAK).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are publicly available. The raw data, dictionary, and code used for the analysis are available at github.io/covid19br/IHFR https://github.com/covid19br/IHFR_manuscript